Sun Yat-sen University Cancer Center

Established in 1964, this is one of the largest and most advanced radiotherapy centers in Asia. It treats over 12,000 patients a year with a precise radiotherapy rate above 95%. Its comprehensive treatment level for nasopharyngeal carcinoma is at a world-leading position, with multiple research results rewriting international guidelines, and it is a benchmark in China's radiotherapy field.

This department was officially established in 2008 and is the leading breast cancer diagnosis and treatment center in South China. It adopts a single-disease multidisciplinary comprehensive treatment model, integrating prevention, diagnosis, treatment and research. With a strong team, its annual diagnosis, treatment and surgical volumes are among the top in the region, at a leading level in China in breast-conserving therapy, breast reconstruction and individualized precision medicine.

A leader in the field of minimally invasive interventional therapy for tumors in China, with two campuses (Yuexiu and Huangpu), 78 open beds and over 16,000 surgeries a year. It has built a system integrating image guidance, multidisciplinary diagnosis and treatment and translational research, with core technologies covering tumor ablation (radiofrequency/microwave/cryo/nano-knife), radioactive seed implantation, hepatic arterial infusion chemotherapy (HAIC) and TIPS, providing efficient minimally invasive solutions for patients who cannot undergo surgery.

Established in 1964, this is one of the earliest head and neck surgery departments in China, with annual surgical volume ranking first among all surgical departments. It is at a leading level in China in standardized diagnosis and treatment, minimally invasive surgery and functional reconstruction of head and neck tumors such as thyroid cancer, laryngeal cancer and oral cancer, with strong research strength and rich clinical experience.

This is one of the centers treating the largest number of nasopharyngeal carcinoma cases globally, with 148 beds. It focuses on epidemiology, early diagnosis and comprehensive treatment of nasopharyngeal carcinoma (including radiotherapy, chemotherapy, minimally invasive surgery and immunotherapy). It is at an internationally leading position in minimally invasive surgery for recurrent nasopharyngeal carcinoma and hyperfractionated radiotherapy, with multiple research results adopted by international guidelines, making it an authoritative center for nasopharyngeal carcinoma diagnosis and treatment in China.